Status:

TERMINATED

The Malaria Heart Disease Study

Lead Sponsor:

University Hospital, Gentofte, Copenhagen

Collaborating Sponsors:

Federal University of Acre

University of Sao Paulo

Conditions:

Plasmodium Falciparum

Plasmodium Vivax

Eligibility:

All Genders

18+ years

Brief Summary

The Malaria Heart Disease Study is a prospective longitudinal cohort study of a random sample of approximately 1200 individuals from the state of Acre in Brazil. The overall hypothesis is that patient...

Detailed Description

The purpose of this study is to investigate the relationship between exposure to malaria and the risk of developing subclinical and manifest cardiovascular disease. The study is conducted in the high ...

Eligibility Criteria

Inclusion

  • Group 1 (History of malaria) Inclusion: Patients with a record of malaria \>=18 years old will be invited at random Exclusion: Persons not able to cooperate and persons unwilling or unable to understand and sign "informed consent", persons who are hospitalized due to severe malaria
  • Group 2 (Controls) Inclusion: Patients with no record of malaria \>=18 years old will be invited at random Exclusion: Persons not able to cooperate and persons unwilling or unable to understand and sign "informed consent"
  • Group 3 (Symptomatic malaria) Inclusion: Patients \>=18 years old diagnosed in outpatient/inpatient clinic with malaria infection by thick and thin blood smear and/or rapid diagnostic test. Enrollment of both severe (complicated) and uncomplicated malaria cases as defined by the WHO criteria. Exclusion: Persons not able to cooperate and persons unwilling or unable to understand and sign "informed consent", suspected or verified concomitant protozoal infections

Exclusion

    Key Trial Info

    Start Date :

    June 21 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 25 2021

    Estimated Enrollment :

    597 Patients enrolled

    Trial Details

    Trial ID

    NCT04445103

    Start Date

    June 21 2020

    End Date

    January 25 2021

    Last Update

    July 19 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Philip Brainin

    Cruzeiro do Sul, Acre, Brazil, 69980000